Sudhir V. Shah

High Impact

Researcher

UAMS primary UA Little Rock

Also affiliated: Tulane University (1981–1992); University of Maryland, Baltimore (2007); United States Department of Veterans Affairs (1981–1983); Mayo Clinic (1978–1982); Sterling Hospitals (2022); Rashtrasant Tukadoji Maharaj Nagpur University (1985); University of British Columbia (2008); Innsbruck Medical University (2008); Taisho Pharmaceutical (Japan) (1991); Emory University (2010); University of Pittsburgh (2008); Universität Innsbruck (2008); University of New Orleans (1979–1991); Zagazig University (1997); Washington University in St. Louis (1990); University of Arkansas Medical Center (2007–2015); University of Arkansas System (2025); Tulane Medical Center (1983–1991); Leicester General Hospital (2008); University Medical Center New Orleans (1983); United States Army Medical Research and Development Command (2002); Jackson Memorial Hospital (1997); Advisory Board Company (United States) (2025); University of Mississippi Medical Center (1996–1998); Ahmedabad Civil Hospital (2016–2021); University of Alabama at Birmingham (2008); National Institute for Health and Care Research (2023); University of California San Diego (2008); Ege University (2007); Central Arkansas Veterans Healthcare System (2000–2025); Suamandeep Vidyapeeth University (2024); Mirai Hospital (2022); Mayo Clinic in Arizona (1978–1981); Diabetes Care & Hormone Clinic (2023); Ospedale San Bortolo (2008); John L. McClellan Memorial Veterans Hospital (1992–2012); Ian's Friends Foundation (2006–2007); Arkansas Department of Agriculture (1999–2004); Smt. N.H.L. Municipal Medical College (2009–2021); Tissue Genetics (United States) (1988); University College London (2023); Institute of Medical Sciences (2021); Indiana University – Purdue University Indianapolis (2007–2008); Jackson State University (1996–1999); International Society of Nephrology (2006–2007); Newcastle University (2023); Mississippi State University (1996)

Faculty Researcher

68 h-index 322 pubs 20,885 cited

Research Areas

Biomedical Subjects

Links

ORCID Research Group

OverviewAI-generated summary

Sudhir V. Shah's research interests encompass patient and public involvement in health sciences, with a particular focus on translating artificial intelligence into clinical practice and understanding behavioral science in healthcare. He has contributed to studies examining the burden of rare genetic disorders and the advancement of CRISPR/Cas9 technology for neurological disorders. His work also includes investigating the management of cardiovascular disease in kidney disease and assessing the utility of clinical exome sequencing for neurodevelopmental disorders.

Shah actively engages with various research initiatives, serving as a lay PPI representative for NIHR Applied Research Collaborations and as an advisory panellist for another ARC. He is a member of an NIHR Patient Safety Translation Research Centre, reviewing research studies with a focus on patient safety and behavioral science, such as statin reluctance. Additionally, he participates in UCL's Co-Production Group for Loneliness and Social Isolation and the Centre for Co-production in Health Research, advising on research funding. He also contributes to the Lived Experience Advisory Panel for Chronic Depression at East London NHS Foundation Trust, aiding in the development of patient and clinician tools.

His scholarly output includes a significant number of publications, reflected in an h-index of 68 and over 20,000 citations. He leads a research group and collaborates with colleagues at the University of Arkansas for Medical Sciences, including Manisha Singh, Oleg Karaduta, Sharda P. Singh, and Judit Megyesi.

Metrics

h-index: 68
Publications: 322
Citations: 20,885

Selected Publications

Effectiveness and efficiency of an add-on active outreach strategy on research enrollments in a drug intervention trial (2025)

DOI OpenAlex
A simpler and more sensitive modified catalytic (bleomycin detectable) iron assay (2025)

1 citation DOI OpenAlex
Iron Chelation Prevents Age‐Related Skeletal Muscle Sarcopenia in Klotho Gene Mutant Mice, a Genetic Model of Aging (2025)

Journal of Cachexia Sarcopenia and Muscle 13 citations DOI OpenAlex
Ophthalmological Safety of Hydroxychloroquine in CKD (2023)

DOI OpenAlex
Vascular Function Indices Are Strong Predictors of the Severity and Characteristics of Carotid Atherosclerosis (2021)

DOI OpenAlex
Management of Cardiovascular Disease in Kidney Disease Study: Rationale and Design (2021)

6 citations DOI OpenAlex
Autophagy Function and Regulation in Kidney Disease (2020)

Biomolecules 107 citations DOI OpenAlex
Home run—results of a chronic kidney disease Telemedicine Patient Education Study (2019)

Clinical Kidney Journal 32 citations DOI OpenAlex
Effects of A Comprehensive Predialysis Education Program on the Home Dialysis Therapies: A Retrospective Cohort Study (2017)

Peritoneal Dialysis International 36 citations DOI OpenAlex
Carbamylated Low-Density Lipoprotein (cLDL)-Mediated Induction of Autophagy and Its Role in Endothelial Cell Injury (2016)

PLoS ONE 23 citations DOI OpenAlex
Proteolytic processing and inactivation of CCL2/MCP-1 by meprins (2016)

Biochemistry and Biophysics Reports 20 citations DOI OpenAlex
Autophagy in acute kidney injury (2016)

Kidney International 385 citations DOI OpenAlex
Impact of Hydroxychloroquine on Atherosclerosis and Vascular Stiffness in the Presence of Chronic Kidney Disease (2015)

PLoS ONE 33 citations DOI OpenAlex
Recent Advances in Understanding the Pathogenesis of Atherosclerosis in CKD Patients (2015)

Journal of Renal Nutrition 17 citations DOI OpenAlex
Evidence Suggesting a Role of Iron in a Mouse Model of Nephrogenic Systemic Fibrosis (2015)

PLoS ONE 17 citations DOI OpenAlex